when i became a women’s health advocate nearly eight years ago, it was fuelled by this overwhelming statistic: 70 per cent of women said they didn’t have anyone to talk to about perimenopause or menopause.
how could such an important part of women’s health remain so under-discussed? i set out to crack open the conversation.
and now, in 2020, we are seeing change.
more women are educating themselves and having informed conversations with their health teams about hormone health. there are more headlines about menopause. the first wave of millennials have turned 35 and they’re starting to get curious about their own perimenopause-to-menopause journey, taking proactive steps and finding health strategies that work for them.
but there is one thing that still keeps me awake at night. navigating women’s midlife health is expensive. and that is what is not being said whenever we talk about perimenopause or menopause.
women aged 35 to 65 hold the most influential positions in society, make the majority of health decisions in a family, and control most of the consumer buying power. yet, their health concerns are not being adequately addressed.
our health care system, employee benefit plans and our investment in women’s health research is not adequately taking care of women. the model is broken and while i’m not sure whose problem it is, i do know it’s time to do something about it.